Arteris, Inc.
Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) | ||||||||
Nine Months Ended
September 30, | ||||||||
2024 | 2023 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net loss | $ | (25,434 | ) | $ | (26,328 | ) | ||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 2,474 | 2,240 | ||||||
Stock-based compensation | 11,807 | 10,981 | ||||||
Amortization of deferred income | (885 | ) | (882 | ) | ||||
Loss from equity method investment | 2,064 | 2,487 | ||||||
Net accretion of discounts on available-for-sale securities | (522 | ) | (698 | ) | ||||
Other, net | 124 | (3 | ) | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 3,288 | (3,225 | ) | |||||
Prepaid expenses and other assets | (1,249 | ) | (495 | ) | ||||
Accounts payable | (43 | ) | (237 | ) | ||||
Accrued expenses and other liabilities | 1,494 | 1,544 | ||||||
Deferred revenue | 8,793 | 1,866 | ||||||
Net cash provided by (used in) operating activities | 1,911 | (12,750 | ) | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Purchases of property and equipment | (274 | ) | (1,075 | ) | ||||
Purchases of available-for-sale securities | (25,997 | ) | (35,373 | ) | ||||
Proceeds from maturities of available-for-sale securities and other | 29,169 | 33,150 | ||||||
Other | | (25 | ) | |||||
Net cash provided by (used in) investing activities | 2,898 | (3,323 | ) | |||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Payments of contingent consideration for business combination | | (1,269 | ) | |||||
Principal payments under vendor financing arrangements | (1,438 | ) | (1,041 | ) | ||||
Proceeds from exercise of stock options | 703 | 460 | ||||||
Payments to tax authorities for shares withheld from employees | | (564 | ) | |||||
Other | 59 | 79 | ||||||
Net cash used in financing activities | (676 | ) | (2,335 | ) | ||||
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | 4,133 | (18,408 | ) | |||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period | 14,084 | 37,423 | ||||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period | $ | 18,217 | $ | 19,015 | ||||
Arteris Announces Financial Results for the Third Quarter 2024 and Fourth Quarter and Full Year 2024 Guidance
| | More EDA News |
|
RELATED NEWS